Discovery of a mammalian FASN inhibitor against xenografts of non-small cell lung cancer and melanoma

被引：0
|
作者：
Danfeng Cao
Jie Yang
Youchao Deng
Meng Su
Yeji Wang
Xueqiong Feng
Yi Xiong
Enhe Bai
Yanwen Duan
Yong Huang
机构：
[1] Xiangya International Academy of Translational Medicine at Central South University,
[2] Xiangya Hospital at Central South University,undefined
[3] National Engineering Research Center of Combinatorial Biosynthesis for Drug Discovery,undefined
来源：
Signal Transduction and Targeted Therapy | / 7卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Discovery of a mammalian FASN inhibitor against xenografts of non-small cell lung cancer and melanoma
    Cao, Danfeng
    Yang, Jie
    Deng, Youchao
    Su, Meng
    Wang, Yeji
    Feng, Xueqiong
    Xiong, Yi
    Bai, Enhe
    Duan, Yanwen
    Huang, Yong
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2022, 7 (01)
  • [2] Discovery of an OTUD3 inhibitor for the treatment of non-small cell lung cancer
    Zhang, Yonghui
    Du, Tongde
    Liu, Na
    Wang, Juan
    Zhang, Lingqiang
    Cui, Chun-Ping
    Li, Chaonan
    Zhang, Xin
    Wu, Bo
    Zhang, Jinhao
    Jiang, Wenli
    Zhang, Yubing
    Zhang, Yuting
    Li, Hongchang
    Li, Peiyu
    CELL DEATH & DISEASE, 2023, 14 (06)
  • [3] Discovery of an OTUD3 inhibitor for the treatment of non-small cell lung cancer
    Yonghui Zhang
    Tongde Du
    Na Liu
    Juan Wang
    Lingqiang Zhang
    Chun-Ping Cui
    Chaonan Li
    Xin Zhang
    Bo Wu
    Jinhao Zhang
    Wenli Jiang
    Yubing Zhang
    Yuting Zhang
    Hongchang Li
    Peiyu Li
    Cell Death & Disease, 14
  • [4] Inhibition of FASN expression enhances radiosensitivity in human non-small cell lung cancer
    Zhan, Ning
    Li, Bin
    Xu, Xiangying
    Xu, Jianyu
    Hu, Songliu
    ONCOLOGY LETTERS, 2018, 15 (04) : 4578 - 4584
  • [5] Impact of the microbiome on checkpoint inhibitor treatment in patients with non-small cell lung cancer and melanoma
    Shaikh, Fyza Y.
    Gills, Joell J.
    Sears, Cynthia L.
    EBIOMEDICINE, 2019, 48 : 642 - 647
  • [6] Phenotyping of lymphoproliferative tumours generated in xenografts of non-small cell lung cancer
    Pearce, David R. R.
    Akarca, Ayse U. U.
    De Maeyer, Roel P. H.
    Kostina, Emily
    Huebner, Ariana
    Sivakumar, Monica
    Karasaki, Takahiro
    Shah, Kavina
    Janes, Sam M. M.
    McGranahan, Nicholas
    Reddy, Venkat
    Akbar, Arne N. N.
    Moore, David A. A.
    Marafioti, Teresa
    Swanton, Charles
    Hynds, Robert E. E.
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [7] Hedgehog Inhibitor and Radiotherapy in Non-small Cell Lung Cancer
    Zeng, J.
    Aziz, K.
    Aftab, B.
    Armour, M.
    Chettair, S.
    Gajula, R.
    Salih, T.
    Rudin, C.
    Tran, P. T.
    Hales, R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S737 - S737
  • [8] Synergistic effects of CBL0137 and gemcitabine against non-small cell lung and pancreatic cancer xenografts
    Burkhart, Catherine
    Kohrn, Rachael
    Walker, Brittany
    Meyer, David
    Gurova, Katerina
    Gudkov, Andrei
    CANCER RESEARCH, 2014, 74 (19)
  • [9] Discovery of CLKs inhibitors for the treatment of non-small cell lung cancer
    Hu, Tianxing
    Huang, Jiali
    Chen, Rui
    Zhang, Hui
    Liu, Mai
    Wang, Renbing
    Zhou, Wenyi
    Huang, Dechun
    Cao, Mingkang
    Li, Depeng
    Li, Zhiyu
    Wu, Hongxi
    Bian, Jinlei
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2024, 280
  • [10] Potential for investigational HER inhibitor in non-small cell lung cancer
    Siddall, Rhonda
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2010, 71 (11) : 611 - 611
12345